Dr. Kannan Vishwanatth of Rupus Global addressed in Plenary Session at the prestigious The Institute Of Economics Of The Latvian Academy of Sciences at Riga.
Headquartered at Hong Kong, Rupus Global Limited (To accelerate its growth engine by revenueamp;global expansion, Rupus Global Limited is exploring new partnership
California [US], May 10 (ANI/NewsVoir): Headquartered at Hong Kong, Rupus Global Limited (rupusglobal.com), one of the fastest growing pharmaceutical company with leadership position in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and provides contract research and manufacturing services (CRAMS) in key segments such as Anti-Inflammatory, Anti-Protozoal, Anti-Diabetic, Vitamins, Anti-Malarial, Anti Cancer has set out an ambitious goal to boost its revenue for 225 Million USD by 2023-24.
Pharma Leaders, Asia most prestigiousamp;much awaited annual healthcare summit will be hosting the high profile 15th Annual Pharma Leaders Summitamp;Power Brand Aw